Seamless and personalized diabetes care has become a new normal.
The FreeStyle Libre 2 now has indications for children ages four and older.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
Skin is a window—it can indicate our overall health. And when it’s damaged, it can hurt both psychologically and physically.
The aging population and the rising rate of diabetes globally are fueling market growth.
The agency is recommending that patients replace their affected pumps with models that can better protect against the risks.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
Technologically superior devices, favorable research outcomes and a supportive regulatory structure are fueling growth.
The new pump allows patients to customize their diabetes management.